1. Home
  2. ENIC vs ACAD Comparison

ENIC vs ACAD Comparison

Compare ENIC & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENIC

Enel Chile S.A. (Each representing 50 shares of)

HOLD

Current Price

$3.87

Market Cap

5.4B

Sector

Utilities

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$27.15

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENIC
ACAD
Founded
2016
1993
Country
Chile
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
ENIC
ACAD
Price
$3.87
$27.15
Analyst Decision
Hold
Buy
Analyst Count
1
21
Target Price
N/A
$29.24
AVG Volume (30 Days)
451.0K
1.6M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
4.78%
N/A
EPS Growth
N/A
98.53
EPS
0.00
1.54
Revenue
$3,760,459,463.00
$1,047,118,000.00
Revenue This Year
$112,978.43
$15.16
Revenue Next Year
$0.35
$11.42
P/E Ratio
$94.99
$17.36
Revenue Growth
N/A
12.69
52 Week Low
$2.73
$13.40
52 Week High
$4.05
$27.73

Technical Indicators

Market Signals
Indicator
ENIC
ACAD
Relative Strength Index (RSI) 54.68 70.39
Support Level $3.81 $26.60
Resistance Level $3.95 $27.73
Average True Range (ATR) 0.08 0.89
MACD 0.01 0.27
Stochastic Oscillator 69.95 87.08

Price Performance

Historical Comparison
ENIC
ACAD

About ENIC Enel Chile S.A. (Each representing 50 shares of)

Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: